Roche

Forecast & Rating8 analysts currently cover Roche, with about 37.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $57.23, about 4.6% upside from the current price of $54.70. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 32.6% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Roche's outlook. Data as of Jul 24, 2026; for reference only and not investment advice.